Angiotensin II Type 1 Receptor Antibodies: Great Expectations?

被引：8
|
作者：
Tinckam, K. [1 ]
Campbell, P. [2 ]
机构：
[1] Univ Hosp Network, Lab Med Program, Toronto, ON, Canada
[2] Univ Alberta, Dept Med & Lab Med, Edmonton, AB, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷 / 10期
关键词：
MEDIATED REJECTION; RISK;
D O I：
10.1111/ajt.12396
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Newly available commercial assays for angiotensin II type 1 receptor antibodies provide an opportunity for examining the role of non-HLA antibodies in kidney transplantation, but data do not yet support their widespread clinical use. See articles by Giral et al (page 2567) and Taniguchi et al (page 2577).
引用
收藏
页码：2515 / 2516
页数：2
相关论文
共 50 条
  • [21] Mapping of angiotensin II binding pocket on angiotensin II type 1 receptor
    Miura, SI
    Zhang, JG
    Boros, J
    Saku, K
    Karnik, SS
    CIRCULATION, 2001, 104 (17) : 145 - 145
  • [22] Impact of Tocilizumab treatment on the reduction of angiotensin II type 1 receptor (AT1R) antibodies
    Taniguchi, M.
    HUMAN IMMUNOLOGY, 2024, 85
  • [23] Angiotensin II Type I Receptor Antibodies and Kidney Graft Outcome
    Piazza, A.
    Ozzella, G.
    Poggi, E.
    Adorno, D.
    TRANSPLANTATION, 2014, 98 : 82 - 83
  • [24] Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature
    Walther, T
    Wallukat, G
    Jank, A
    Bartel, S
    Schultheiss, HP
    Faber, R
    Stepan, H
    HYPERTENSION, 2005, 46 (06) : 1275 - 1279
  • [25] Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection
    Lee, Hyeyoung
    Kim, Ji-Il
    Moon, In-Sung
    Chung, Byung Ha
    Yang, Chul-Woo
    Kim, Yonggoo
    Han, Kyungja
    Oh, Eun-Jee
    ANNALS OF LABORATORY MEDICINE, 2015, 35 (03) : 314 - 320
  • [26] Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease
    De-Hyung Lee
    Harald Heidecke
    Alexandra Schröder
    Friedemann Paul
    Rolf Wachter
    Rainer Hoffmann
    Gisa Ellrichmann
    Duska Dragun
    Anne Waschbisch
    Johannes Stegbauer
    Peter Klotz
    Ralf Gold
    Ralf Dechend
    Dominik N Müller
    Carsten Saft
    Ralf A Linker
    Molecular Neurodegeneration, 9
  • [27] Angiotensin II Type 1 Receptor Antibodies in Multiple Sclerosis: A New Biomarker for Disease Activity?
    Schroeder, Alexandra
    Heidecke, Harald
    Lee, De-Hyung
    Muller, Dominik
    Stegbauer, Johannes
    Gold, Ralf
    Linker, Ralf
    NEUROLOGY, 2010, 74 (09) : A154 - A154
  • [28] Angiotensin II Type-1 Receptor Antibodies are Associated with Inferior Renal Allograft Survival
    Martin, P.
    Santos, E.
    Gunby, N.
    Willicombe, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 377 - 378
  • [29] ANGIOTENSIN II TYPE 1 RECEPTOR ANTIBODIES IN A CASE OF HYPERACUTE RENAL ALLOGRAFT REJECTION.
    Lunz, John G.
    Shapiro, Ron
    Randawa, Parmjeet
    Heidecke, Harald
    Dragun, Duska
    Zeevi, Adriana
    HUMAN IMMUNOLOGY, 2010, 71 : S122 - S122
  • [30] ANGIOTENSIN II TYPE 1-RECEPTOR ANTIBODIES IN HIGHLY SENSITIZED RENAL TRANSPLANT CANDIDATES
    Vittoraki, Angeliki G.
    Markaki, Pavlina V.
    Chouliari, Niki V.
    Skoumi, Dimitra A.
    Ioannou, Sofia I.
    Apostolaki, Maria D.
    Iniotaki, Aliki G.
    HLA, 2017, 89 (06) : 384 - 385
12345